QUANTUM-SI INC (QSI)

US74765K1051 - Common Stock

1.31  +0.01 (+0.77%)

After market: 1.33 +0.02 (+1.53%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to QSI. QSI was compared to 57 industry peers in the Life Sciences Tools & Services industry. No worries on liquidiy or solvency for QSI as it has an excellent financial health rating, but there are worries on the profitability. QSI is quite expensive at the moment. It does show a decent growth rate.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

QSI had negative earnings in the past year.
In the past year QSI has reported a negative cash flow from operations.
In the past 5 years QSI always reported negative net income.
QSI had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of QSI (-38.03%) is worse than 77.19% of its industry peers.
QSI has a worse Return On Equity (-42.72%) than 64.91% of its industry peers.
Industry RankSector Rank
ROA -38.03%
ROE -42.72%
ROIC N/A
ROA(3y)-28.29%
ROA(5y)N/A
ROE(3y)-30.72%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of QSI (51.54%) is better than 61.40% of its industry peers.
The Profit Margin and Operating Margin are not available for QSI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 51.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

7

2. Health

2.1 Basic Checks

QSI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, QSI has more shares outstanding
There is no outstanding debt for QSI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

QSI has an Altman-Z score of 0.46. This is a bad value and indicates that QSI is not financially healthy and even has some risk of bankruptcy.
QSI has a Altman-Z score of 0.46. This is in the lower half of the industry: QSI underperforms 66.67% of its industry peers.
QSI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.46
ROIC/WACCN/A
WACC11.27%

2.3 Liquidity

QSI has a Current Ratio of 13.42. This indicates that QSI is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 13.42, QSI belongs to the best of the industry, outperforming 96.49% of the companies in the same industry.
A Quick Ratio of 13.15 indicates that QSI has no problem at all paying its short term obligations.
QSI has a better Quick ratio (13.15) than 96.49% of its industry peers.
Industry RankSector Rank
Current Ratio 13.42
Quick Ratio 13.15

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.79% over the past year.
Looking at the last year, QSI shows a very strong growth in Revenue. The Revenue has grown by 233.24%.
EPS 1Y (TTM)15.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.88%
Revenue 1Y (TTM)233.24%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%252.91%

3.2 Future

The Earnings Per Share is expected to grow by 3.16% on average over the next years.
Based on estimates for the next years, QSI will show a very strong growth in Revenue. The Revenue will grow by 162.83% on average per year.
EPS Next Y0.49%
EPS Next 2Y-10.7%
EPS Next 3Y-5.25%
EPS Next 5Y3.16%
Revenue Next Year231.42%
Revenue Next 2Y200.89%
Revenue Next 3Y180.63%
Revenue Next 5Y162.83%

3.3 Evolution

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

QSI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year QSI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A cheap valuation may be justified as QSI's earnings are expected to decrease with -5.25% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-10.7%
EPS Next 3Y-5.25%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for QSI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

QUANTUM-SI INC

NASDAQ:QSI (12/23/2024, 7:33:41 PM)

After market: 1.33 +0.02 (+1.53%)

1.31

+0.01 (+0.77%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)N/A N/A
Inst Owners37.24%
Inst Owner Change-2.63%
Ins Owners5.6%
Ins Owner Change1.9%
Market Cap186.95M
Analysts76.67
Price Target3.32 (153.44%)
Short Float %9.28%
Short Ratio0.73
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.61%
Min EPS beat(2)8.61%
Max EPS beat(2)16.62%
EPS beat(4)4
Avg EPS beat(4)16.98%
Min EPS beat(4)8.61%
Max EPS beat(4)30.69%
EPS beat(8)7
Avg EPS beat(8)10.35%
EPS beat(12)9
Avg EPS beat(12)2.41%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-18.58%
Min Revenue beat(2)-27.8%
Max Revenue beat(2)-9.37%
Revenue beat(4)2
Avg Revenue beat(4)0.29%
Min Revenue beat(4)-27.8%
Max Revenue beat(4)32.23%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)30%
PT rev (3m)18.18%
EPS NQ rev (1m)0%
EPS NQ rev (3m)11.36%
EPS NY rev (1m)-0.22%
EPS NY rev (3m)4.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-27.03%
Revenue NY rev (1m)-20.76%
Revenue NY rev (3m)-20.76%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 82.5
P/FCF N/A
P/OCF N/A
P/B 0.89
P/tB 0.89
EV/EBITDA N/A
EPS(TTM)-0.64
EYN/A
EPS(NY)-0.83
Fwd EYN/A
FCF(TTM)-0.62
FCFYN/A
OCF(TTM)-0.6
OCFYN/A
SpS0.02
BVpS1.48
TBVpS1.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -38.03%
ROE -42.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 51.54%
FCFM N/A
ROA(3y)-28.29%
ROA(5y)N/A
ROE(3y)-30.72%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 60.4%
Cap/Sales 125.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 13.42
Quick Ratio 13.15
Altman-Z 0.46
F-Score4
WACC11.27%
ROIC/WACCN/A
Cap/Depr(3y)365.67%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.88%
EPS Next Y0.49%
EPS Next 2Y-10.7%
EPS Next 3Y-5.25%
EPS Next 5Y3.16%
Revenue 1Y (TTM)233.24%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%252.91%
Revenue Next Year231.42%
Revenue Next 2Y200.89%
Revenue Next 3Y180.63%
Revenue Next 5Y162.83%
EBIT growth 1Y2.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year13.67%
EBIT Next 3Y-2.33%
EBIT Next 5Y4.29%
FCF growth 1Y10.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3.15%
OCF growth 3YN/A
OCF growth 5YN/A